Orange Book product · Generic (ANDA)
TESTOSTERONE CYPIONATE
TESTOSTERONE CYPIONATE
At a glance
Jun 19, 2018
Approved
Generic (ANDA)
Application
AO
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 19, 2018
8 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
TESTOSTERONE CYPIONATE
Strength
100MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AO
Application
ANDA 210362
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TESTOSTERONE CYPIONATE
- 2022AZMIROBrand (NDA)
NDA 216318 · AZURITY
- 2023TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 211817 · EUGIA PHARMA
- 2023TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 215351 · XIROMED
- 2019TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 206368 · WILSHIRE PHARMS INC
- 2017TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 207742 · AM REGENT
- 2013TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 201720 · SUN PHARM INDS LTD
- 2012TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 091244 · HIKMA FARMACEUTICA
- 2010TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 090387 · HIKMA
- 2006TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 040652 · RISING
- 2006TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 040615 · CAPLIN ONE LABS
- 2005TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 040530 · PADAGIS US
- —DEPO-TESTOSTERONEGeneric (ANDA)
ANDA 085635 · PFIZER
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
